Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2008
11/18/2008CA2143752C Method of preventing nmda receptor-mediated neuronal damage
11/18/2008CA2133587C Compounds having selectivity for retinoid x receptors
11/13/2008WO2008137060A1 Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity
11/13/2008WO2008136519A1 Cytotoxic t cell activator comprising ep4 agonist
11/13/2008WO2008136457A1 Nitrogen-containing aromatic derivative
11/13/2008WO2008136444A1 Fused heterocyclic derivative
11/13/2008WO2008136428A1 Nitrogen-containing five-membered heterocyclic compound
11/13/2008WO2008136382A1 Bicyclic compound and pharmaceutical use thereof
11/13/2008WO2008136378A1 Novel sulfonamide derivative and salt thereof
11/13/2008WO2008136377A1 Bicyclic heterocyclic compound
11/13/2008WO2008136213A1 Radiosensitivity-enhancing agent
11/13/2008WO2008136173A1 Adipocyte differentiation inhibitor containing stilbene derivative as active ingredient
11/13/2008WO2008136059A1 Composition for improving vascular endothelial function
11/13/2008WO2008135522A1 Use of s1p receptor modulator
11/13/2008WO2008089403A3 Oligosaccharides comprising an aminooxy group and conjugates thereof
11/13/2008WO2008067049A3 Particles for cell targeting
11/13/2008WO2008013631A3 Composition for the enterosorption and management of toxins comprising a calcium aluminosilcilate clay
11/13/2008WO2007126958A3 Tumor cell differentiation agents as chemical inhibitors and treatments for intracellular parasites
11/13/2008US20080281092 Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
11/13/2008US20080281084 Using charged polymers to enhance solubility of polypeptide in aqueous solutions
11/13/2008US20080280998 Bifunctional Derivatives of Polyethylene Glycol, Their Preparation and Use
11/13/2008US20080280984 Transdermal Delivery of Beneficial Substances Effected By a Hostile Biophysical Environment
11/13/2008US20080280980 Treatment and Prevention of Bone Loss Using Resolvins
11/13/2008US20080280972 Iminosugar treatment of tumors
11/13/2008US20080280967 Antiarthritic agents; antiinflammatory agents; inflammatory bowel disorders; graft verses host disease; antiulcer agents; skin disorders; respiratory system disorders; anticancer agents
11/13/2008US20080280958 Administering a phosphodiesterase inhibitor; bioavailability; skin disorders; respiratory system disorders; using roflumilast
11/13/2008US20080280909 New phenylalanine derivatives
11/13/2008US20080280903 antiapoptosis agents such as 1-[2-Methoxyimino-2-(4-pyrrolidin-1-yl-phenyl)-ethyl]-quinolinium bromide, used for cytoprotection or for side effect reduction of anticarcinogenic agents
11/13/2008US20080280863 Concurrent administering by mouth a corticosteroid and tricyclic antidepressant compound; immunoinflamamtory disorders; antiarthritic agents; skin disorders; inflammatory bowel disorders; Crohn's disorders; autoimmune disease; asthma; multiple sclerosis; diabetes; lupus
11/13/2008US20080280858 Method of creating crystalline substances
11/13/2008US20080280854 Preventing or reducing oxidative stress or oxidative cell injury
11/13/2008US20080280848 Structures of Active Guide Rna Molecules and Method of Selection
11/13/2008US20080280847 small interfering RNAs (siRNAs) to identify nucleotides encoding proteins involved in the co-transport of inorganic phosphate in vascular tissues; therapeutics
11/13/2008US20080280818 Glycosylation of peptides via o-linked glycosylation sequences
11/13/2008US20080280354 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
11/13/2008US20080280308 G protein coupled receptor signaling modulation
11/13/2008US20080279970 Pharmaceutical composition for treating parotid gland tumor, cerebroma and renal cyst
11/13/2008US20080279955 Pharmaceutical microparticles
11/13/2008US20080279954 Drug delivery; therapeutic agent and crosslinked polymer network
11/13/2008US20080279949 Such as paclitaxel and stabilizer
11/13/2008US20080279947 Menthol-Containing Solids Composition
11/13/2008US20080279946 Methods and compositions for increasing infrared absorptivity of a target
11/13/2008US20080279940 For treatment or prevention of chronic pain
11/13/2008US20080279935 Composition Comprising a Powder Containing Microencapsulated Polyunsaturated Long-Chain Esterified Fatty Acids Distributed in an Effervescent Base
11/13/2008US20080279930 Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
11/13/2008US20080279929 Nanoparticulate and Controlled Release Compositions Comprising Cefditoren
11/13/2008US20080279921 Gel-formulations of hydrophobic photosensitizers for mucosal applications
11/13/2008US20080279919 Liposomes for protection against toxic compounds
11/13/2008US20080279916 Liposome Preparation
11/13/2008US20080279855 Dna Replication Modulating Peptides, Nucleic Acids Encoding Them, and Their Use in Pharmaceutical Compositions
11/13/2008US20080279852 Methods of treatment with glycosylated antibodies
11/13/2008US20080279841 Novel Therapeutic Molecular Variants And Uses Thereof
11/13/2008US20080279824 Articles for tissue regeneration with biodegradable polymer
11/13/2008US20080279781 Glycosylated Carboranylporphyrins and Uses Thereof
11/13/2008US20080279767 Cancerous disease modifying antibodies
11/13/2008DE10362194B4 Verfahren zum Testen der Aktivität einer möglichen wirksamen Substanz, die die enzymatische Aktivität der Phospholipase A2 hemmen kann A method for testing the activity of a possible active substance which inhibit the enzymatic activity of phospholipase A2 can
11/13/2008CA2685216A1 Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity
11/13/2008CA2684953A1 Use of s1p receptor modulator
11/13/2008CA2684922A1 Cytotoxic t cell activator comprising ep4 agonist
11/13/2008CA2684703A1 Bicyclic compound and pharmaceutical use thereof
11/12/2008EP1990427A1 Npy y4 agonist as therapeutic agent for disease accompanied by intestinal tract dysfunction
11/12/2008EP1990415A1 Osteoprotegerin
11/12/2008EP1990413A1 Screening method for candidate drugs
11/12/2008EP1990343A2 Azaindoles
11/12/2008EP1990341A1 Triazolyl tropane derivatives as CCR5 modulators
11/12/2008EP1990056A1 Tooth root formation promoter and method for promotion of tooth root formation
11/12/2008EP1990051A1 Combinations of SSRI and estrogenic agents
11/12/2008EP1990049A2 Combination therapy of beta-blockers and non-steroidal anti-inflammatory drugs (NSAID)
11/12/2008EP1990046A1 Condensation aerosol containing loxapine or prochlorperazine for inhalation
11/12/2008EP1990040A1 Nanoparticle delivery vehicle
11/12/2008EP1989330A2 Alpha-synuclein kinase
11/12/2008EP1989144A2 An extracorporeal cell-based therapeutic device and delivery system
11/12/2008EP1988906A2 Method for accelerating reentrainment of a circadian rhythm
11/12/2008EP1988892A2 Modulators of muscarinic receptors
11/12/2008EP1988885A2 Combination of organic compounds
11/12/2008EP1561759B1 Cell death-inducing agent
11/12/2008EP1478659B1 Biologically active peptides
11/12/2008EP1472278B1 Macrocyclic peptides active against the hepatitis c virus
11/12/2008EP1424894B1 Inhibition of pathological angiogenesis in vivo
11/12/2008EP1409468B1 Guanidinobenzamides as mc4-r agonists
11/12/2008EP1404811B1 Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis
11/12/2008EP1404305B1 Pharmacological preparation made from a nanoparticulate mesomorphous polyelectrolyte lipid complex and at least one active ingredient
11/12/2008EP1365771B9 Method of treating certain eye diseases
11/12/2008EP1315490B1 A method for treating allergies using substituted pyrazoles
11/12/2008EP1261607B1 2,4-disubstituted thiazolyl derivatives
11/12/2008EP0950103B1 Survivin, a protein that inhibits cellular apoptosis, and its modulation
11/12/2008EP0750668B1 Novel muteins of ifn-beta
11/12/2008EP0701569B1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
11/12/2008CN101305007A Pyrazolo[4,3-d]pyrimidin-5-yl)derivative used as PDE5 inhibitors
11/12/2008CN101304985A Thiazole compounds and their use as PGD2 antagonists
11/12/2008CN101302192A Prodrug forms of ribonucleotide reductase inhibitors 3-AP and 3-AMP
11/12/2008CN101302182A Virus polymerase inhibitors
11/12/2008CN101301405A External-use medicament for treating hernia
11/12/2008CN101301400A Camellia functional instant formulation and preparation thereof
11/12/2008CN101301305A Flavin adenine dinucleotide disodium salt freeze-dried powder needle preparation and preparation thereof
11/12/2008CN101301294A Combinated inhibitors of FBP-ase and antidiabetic agents for diabetes treatment
11/12/2008CN101301286A Novel use of brasilein
11/12/2008CN101301277A Freeze-dried injection of Meglumine Glycididazole and preparation thereof
11/12/2008CN101301102A Heatstroke prevention functional drink
11/12/2008CN100432229C Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
1 ... 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 ... 1564